ClinicalTrials.Veeva

Menu
E

EMMED Research | Jakaranda Hospital

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Etrolizumab
UPB-101
Oseltamivir
Pimodivir
Tofacitinib
Verekitug
Baloxavir Marboxil
Ibrexafungerp
Peramivir
Pemafibrate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 39 total trials

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...

Active, not recruiting
Severe Asthma
Drug: Verekitug
Drug: Placebo

This study is comparing 200 milligrams (mg) of filgotinib a day with a placebo to see if filgotinib helps to treat Axial Spondyloarthritis (axSpA) an...

Active, not recruiting
Axial Spondyloarthritis
Drug: Placebo
Drug: Filgotinib

The purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab in participants with moderat...

Active, not recruiting
Colitis, Ulcerative
Biological: JNJ-78934804
Drug: Placebo

The purpose of this study is to test the efficacy and safety of orforglipron in participants with T2D (type 2 diabetes) who participate in fasting du...

Begins enrollment this month
Behavior
Glucagon-Like Peptide-1 Receptor
Drug: Orforglipron

This study will assess how mosunetuzumab works in people who have systemic lupus erythematosus (SLE) who may or may not also have active lupus nephri...

Enrolling
Lupus Nephritis
Lupus
Drug: Mosunetuzumab

This parallel-group, double-blind, placebo-controlled study will evaluate the efficacy and safety of obinutuzumab versus placebo in participants with...

Active, not recruiting
Systemic Lupus Erythematosus
Drug: Methylprednisolone
Drug: Acetaminophen/Paracetamol

The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to pla...

Active, not recruiting
Influenza
Combination Product: CD388 Injection
Combination Product: Placebo

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Active, not recruiting
Lower Respiratory Tract Illness
Biological: RSVpreF
Biological: Placebo

Trial sponsors

Pfizer logo
Roche logo
Janssen (J&J Innovative Medicine) logo
Lilly logo
U
AbbVie logo
A
BioCryst logo
B
Boehringer Ingelheim logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems